Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 50.73

-5.2%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: RCMac who wrote (5320)	1/4/2002 9:11:45 AM
From: Biomaven	Read Replies (2) of 52153

RCM, I've been thinking more about why Roche hasn't settled, and I wonder if it may have to do with the terms of their Boehringer Ingelheim acquisition. It has been reported that Roche kept back a billion dollars in their acquisition to pay for potential lawsuits. I could imagine that the terms of that agreement allow for either BI to approve any settlement or for the holdback to be retained by Roche only if Roche actually loses a judicial decision. If a potential settlement is over a billion, BI would have no incentive to approve, and so Roche is forced to go to court and wait for a judicial decision setting damages. What do you think of this speculation? Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next